Insider · CIK 0001352992

Keller Deborah L

Reports to the SEC for 3 companies · EXTON, PA

sec.gov

Transactions

Companies

Filings

CIK

0001352992

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-04	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+791 sh	—	—	11,560.479
2025-05-06	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+1,071 sh	—	—	10,656.72
2024-04-23	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+564 sh	—	—	9,585.72
2023-04-25	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+616 sh	—	—	9,021.72
2022-05-24	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+632 sh	—	—	8,405.72
2021-05-04	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+577 sh	—	—	7,773.72
2020-05-05	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+975 sh	—	—	7,180.341
2019-05-07	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+1,565 sh	—	—	4,880.747
2018-12-31	WSTWEST PHARMACEUTICAL SERVICES INC · Phantom Stock UnitA Award	Director	AAward	+204 sh	$98.03	+$20K	1,278.871
2018-09-28	WSTWEST PHARMACEUTICAL SERVICES INC · Phantom Stock UnitA Award	Director	AAward	+162 sh	$123.74	+$20K	1,072.251
2018-06-29	WSTWEST PHARMACEUTICAL SERVICES INC · Phantom Stock UnitA Award	Director	AAward	+202.145 sh	$99.29	+$20.1K	910.251
2018-05-01	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+1,824 sh	—	—	3,309.213
2018-03-29	WSTWEST PHARMACEUTICAL SERVICES INC · Phantom Stock UnitA Award	Director	AAward	+227.671 sh	$86.72	+$19.7K	708.107
2017-12-29	WSTWEST PHARMACEUTICAL SERVICES INC · Phantom Stock UnitA Award	Director	AAward	+202.079 sh	$99.16	+$20K	480.436
2017-09-29	WSTWEST PHARMACEUTICAL SERVICES INC · Phantom Stock UnitA Award	Director	AAward	+207.62 sh	$96.33	+$20K	278.358
2017-06-30	WSTWEST PHARMACEUTICAL SERVICES INC · Phantom Stock UnitA Award	Director	AAward	+70.633 sh	$94.39	+$6,667.002	70.633
2017-06-01	WSTWEST PHARMACEUTICAL SERVICES INCA Award	Director	AAward	+1,483 sh	—	—	1,483
2016-03-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	CEO, Covance Drug Development	MExercise/Conversion	+1,220 sh	—	—	12,632
2016-03-11	LHLABCORP HOLDINGS INC.F Tax Payment	CEO, Covance Drug Development	FTax Payment	−374 sh	$115.49	−$43.2K	12,257
2016-03-11	LHLABCORP HOLDINGS INC.M Exercise/Conversion	CEO, Covance Drug Development	MExercise/Conversion	+11.7K sh	—	—	23,967
2016-03-11	LHLABCORP HOLDINGS INC.F Tax Payment	CEO, Covance Drug Development	FTax Payment	−4,213 sh	$115.49	−$487K	19,754
2016-03-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	CEO, Covance Drug Development	MExercise/Conversion	−1,220 sh	—	—	29,980
2016-03-11	LHLABCORP HOLDINGS INC. · Restricted Stock UnitM Exercise/Conversion	CEO, Covance Drug Development	MExercise/Conversion	−11.7K sh	—	—	18,270
2016-02-09	LHLABCORP HOLDINGS INC. · Restricted Stock UnitA Award	CEO, Covance Drug Development	AAward	+4,120 sh	—	—	31,200
2015-02-19	COVANCE INCA Award	Corp. Executive Vice President	AAward	+4,190 sh	—	—	63,144
2015-02-19	COVANCE INCF Tax Payment	Corp. Executive Vice President	FTax Payment	−20.7K sh	$107.19	−$2.21M	42,488
2015-02-19	COVANCE INCD Disposition to Issuer	Corp. Executive Vice President	DDisposition to Issuer	−42.5K sh	—	—	0
2015-02-19	COVANCE INCStock Option (Right to Buy)D Disposition to Issuer	Corp. Executive Vice President	DDisposition to Issuer	−2,339 sh	—	—	0
2015-02-19	COVANCE INCStock Option (Right to Buy)D Disposition to Issuer	Corp. Executive Vice President	DDisposition to Issuer	−13.3K sh	—	—	0
2015-02-19	COVANCE INCStock Option (Right to Buy)D Disposition to Issuer	Corp. Executive Vice President	DDisposition to Issuer	−2,600 sh	—	—	0
2015-02-19	COVANCE INCStock Option (Right to Buy)D Disposition to Issuer	Corp. Executive Vice President	DDisposition to Issuer	−9,000 sh	—	—	0
2015-02-19	COVANCE INCStock Option (Right to Buy)D Disposition to Issuer	Corp. Executive Vice President	DDisposition to Issuer	−10.5K sh	—	—	0
2015-02-19	COVANCE INCStock Option (Right to Buy)D Disposition to Issuer	Corp. Executive Vice President	DDisposition to Issuer	−11.7K sh	—	—	0
2014-12-17	COVANCE INCF Tax Payment	Corp. Executive Vice President	FTax Payment	−3,692 sh	$102.61	−$379K	58,954
2014-12-05	COVANCE INCM Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	+400 sh	$62.65	+$25.1K	58,816
2014-12-05	COVANCE INCM Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	+4,600 sh	$81.40	+$374K	63,416
2014-12-05	COVANCE INCM Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	+13.5K sh	$58.37	+$788K	76,916
2014-12-05	COVANCE INCM Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	+3,500 sh	$69.01	+$242K	80,416
2014-12-05	COVANCE INCS Sale	Corp. Executive Vice President	SSale	−17.8K sh	$103.13	−$1.83M	62,646
2014-12-05	COVANCE INCStock Option (Right to Buy)M Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	−400 sh	—	—	0
2014-12-05	COVANCE INCStock Option (Right to Buy)M Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	−4,600 sh	—	—	0
2014-12-05	COVANCE INCStock Option (Right to Buy)M Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	−13.5K sh	—	—	2,600
2014-12-05	COVANCE INCStock Option (Right to Buy)M Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	−3,500 sh	—	—	10,500
2014-02-18	COVANCE INCA Award	Corp. Executive Vice President	AAward	+11.5K sh	—	—	58,879
2014-02-18	COVANCE INCF Tax Payment	Corp. Executive Vice President	FTax Payment	−463 sh	$101.95	−$47.2K	58,416
2014-02-18	COVANCE INCStock Option (Right to Buy)A Award	Corp. Executive Vice President	AAward	+11.7K sh	—	—	11,700
2014-02-07	COVANCE INCM Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	+11.1K sh	$39.80	+$442K	61,584
2014-02-07	COVANCE INCS Sale	Corp. Executive Vice President	SSale	−14.2K sh	$98.14	−$1.39M	47,419
2014-02-07	COVANCE INCStock Option (Right to Buy)M Exercise/Conversion	Corp. Executive Vice President	MExercise/Conversion	−11.1K sh	—	—	2,339
2013-12-17	COVANCE INCF Tax Payment	Corp. Executive Vice President	FTax Payment	−2,545 sh	$84.31	−$215K	50,484

Recent filings

Accepted (ET)
May 64
Keller Deborah L0000105770-26-000062
SEC(opens sec.gov)
May 84
Keller Deborah L0001127602-25-013700
SEC(opens sec.gov)
Apr 254
Keller Deborah L0001127602-24-013404
SEC(opens sec.gov)
Apr 274
Keller Deborah L0001562180-23-003694
SEC(opens sec.gov)
May 264
Keller Deborah L0001562180-22-004426
SEC(opens sec.gov)
May 64
Keller Deborah L0001562180-21-003306
SEC(opens sec.gov)
May 74
Keller Deborah L0001562180-20-003470
SEC(opens sec.gov)
May 94
Keller Deborah L0001562180-19-002727
SEC(opens sec.gov)
Jan 34
Keller Deborah L0001562180-19-000128
SEC(opens sec.gov)
Oct 24
Keller Deborah L0001562180-18-004089
SEC(opens sec.gov)
Aug 14
Keller Deborah L0001562180-18-003446
SEC(opens sec.gov)
May 34
Keller Deborah L0001562180-18-002197
SEC(opens sec.gov)
Oct 34
Keller Deborah L0001562180-17-003160
SEC(opens sec.gov)
Jul 54
WEST PHARMACEUTICAL SERVICES INC0001562180-17-002376
SEC(opens sec.gov)
Jun 24
WEST PHARMACEUTICAL SERVICES INC0001562180-17-002114
SEC(opens sec.gov)
Mar 154
LABORATORY CORP OF AMERICA HOLDINGS0001127602-16-046303
SEC(opens sec.gov)

Companies

Address

530 HERMAN O. WEST DRIVE

EXTON, PA, 19341